InChI=1S/C44H74NO10P/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-25-27-29-31-33-35-42(46)52-37-40(38-53-56(50,51)54-39-41(45)44(48)49)55-43(47)36-34-32-30-28-26-23-16-14-12-10-8-6-4-2/h5,7,11,13,17-18,20-21,24-25,29,31,40-41H,3-4,6,8-10,12,14-16,19,22-23,26-28,30,32-39,45H2,1-2H3,(H,48,49)(H,50,51)/b7-5-,13-11-,18-17-,21-20-,25-24-,31-29-/t40-,41+/m1/s1 |
JXLHYMMCWFGINH-MUPPCIMWSA-N |
[H][C@](COP(OC[C@@](COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)(OC(CCCCCCCCCCCCCCC)=O)[H])(=O)O)(C(O)=O)N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via phosphatidyl-L-serine )
|
|
View more via ChEBI Ontology
(2S)-2-amino-3-({[(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid
|
HMDB
|
1-Docosahexaenoyl-2-palmitoyl-sn-glycero-3-phosphoserine
|
HMDB
|
Phosphatidylserine(22:6/16:0)
|
HMDB
|
Phosphatidylserine(22:6n3/16:0)
|
HMDB
|
Phosphatidylserine(22:6w3/16:0)
|
HMDB
|
Phosphatidylserine(38:6)
|
HMDB
|
PS(22:6/16:0)
|
HMDB
|
PS(22:6n3/16:0)
|
HMDB
|
PS(22:6w3/16:0)
|
HMDB
|
PS(38:6)
|
HMDB
|
PSer(22:6/16:0)
|
HMDB
|
PSer(22:6n3/16:0)
|
HMDB
|
PSer(22:6w3/16:0)
|
HMDB
|
PSer(38:6)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|